Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

BI-1206, a Monoclonal Antibody Against Fcγriib, Showed Superior Anti-Tumor Activity in an Ibrutinib-Venetoclax Dual Resistant PDX Model in Mantle Cell Lymphoma

Changying Jiang, PhD, Yang Liu, MD, Joseph Mitchell McIntosh, Angela Leeming, Rongjia Zhang, William Lee, Krystle Nomie, PhD, Ingrid Karlsson, PhD, Linda Mårtensson, PhD, Mathilda Kovacek, Ingrid Teige, PhD, Björn Frendéus, PhD, Michael L. Wang, MD

Blood (2019) 134 (Supplement_1): 2863.

https://doi.org/10.1182/blood-2019-126957

Published: 2019

Journal Articles

Prognostic Impact of Germ-Line FCGR2A (H131R), FCGR3A (F158V), and FCGR2B (I232T) Single Nucleotide Polymorphisms in Lymphoma Patients Treated with Obinutuzumab or Rituximab in Combination with Chemotherapy: Results from the Phase III GALLIUM and GOYA Clinical Trials

Blood (2018) 132 (Supplement 1): 4109.

https://doi.org/10.1182/blood-2018-99-116750

Published: 2018

Journal Articles

Use of Monoclonal Antibodies to RBC Antigens As a Therapeutic to Allow Incompatible Transfusion

Hayley Waterman, Heather Howie, PhD, Xiaohong Wang, PhD, James C. Zimring, MD PhD

Blood (2015) 126 (23): 1140.

https://doi.org/10.1182/blood.V126.23.1140.1140

Published: 2015

Journal Articles

Interim Results From a Phase Ib/IIa Clinical Trial with the Soluble Fc-Gamma IIb Receptor SM101 for the Treatment of Primary Immune Thrombocytopenia

Tatyana Semenovna Konstaninova, Ivanova Valentina Leonidovna, Andrzej Hellmann, Slawomira Kyrcz-Krzemien, MD PhD Prof, Sascha Tillmanns, Peter Sondermann, Peter Buckel

Blood (2012) 120 (21): 3388.

https://doi.org/10.1182/blood.V120.21.3388.3388

Published: 2012

Journal Articles

Properties of mouse and human IgG receptors and their contribution to disease models

Pierre Bruhns

Blood (2012) 119 (24): 5640–5649.

https://doi.org/10.1182/blood-2012-01-380121

Published: 2012

Journal Articles

Human FcγRIIA induces anaphylactic and allergic reactions

Friederike Jönsson, David A. Mancardi, Wei Zhao, Yoshihiro Kita, Bruno Iannascoli, Huot Khun, Nico van Rooijen, Takao Shimizu, Lawrence B. Schwartz, Marc Daëron, Pierre Bruhns

Blood (2012) 119 (11): 2533–2544.

https://doi.org/10.1182/blood-2011-07-367334

Published: 2012

Includes: Supplemental data

Journal Articles

Correlation of Fc Gamma RIIA Polymorphisms with EBV-Positivity and LMP1 Expression in Patients with Low Grade B-Cell Lymphomas

Panagiotis Theodorou Diamantopoulos, Vassiliki Kalotychou, Athanassios Galanopoulos, Nikolaos Spanakis, Katerina Polonyfi, Georgia Diamantopoulou, Efthymia Bazanis, Marina Siakantaris, M.D., Theodoros Vassilakopoulos, Maria K. Angelopoulou, Eleni Variami, Nikolaos Anagnostopoulos, Ioannis Rombos, Konstantinos Konstantopoulos, Panagoula Kollia, Gerasimos Pangalis, John Meletis, Nora-Athina Viniou

Blood (2011) 118 (21): 1600.

https://doi.org/10.1182/blood.V118.21.1600.1600

Published: 2011

Journal Articles

Comparison of Platelet-Activating Potential of Bevacizumab+VEGF and Aflibercept+VEGF Complexes

Todd Meyer, PhD., Liza Robles-Carrillo, M.S., Hina Desai, M.S., Meghan Hatfield, M.S., Mildred Amaya, M.S., John Francis, PhD, Ali Amirkhosravi, PhD.

Blood (2010) 116 (21): 3200.

https://doi.org/10.1182/blood.V116.21.3200.3200

Published: 2010

Journal Articles

An Fc-Engineered Humanized Anti-CD40 Monoclonal Antibody, XmAb5485, Exhibits Potent Activity in Vitro and in Vivo against Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma

Eugene A. Zhukovsky, PhD, Holly Horton, Ph.D, Matthias Peipp, PhD, Erik Pong, BS, Matthew Bernett, PhD, Sher Karki, PhD, John Richards, PhD, Seung Chu, PhD, Roland Repp, MD, John Desjarlais, PhD

Blood (2008) 112 (11): 881.

https://doi.org/10.1182/blood.V112.11.881.881

Published: 2008

Journal Articles

XmAb™ Fc Engineered Anti-CD19 Monoclonal Antibody with Enhanced In Vitro Efficacy Against Lymphoma and Leukemia.

Eugene Zhukovsky, PhD, Seung Chu, PhD, Matthew Bernett, PhD, Sher Karki, PhD, John Richards, PhD, Erik Pong, BS, Matthias Peipp, PhD, Roland Repp, MD, John Desjarlais, PhD

Blood (2007) 110 (11): 2335.

https://doi.org/10.1182/blood.V110.11.2335.2335

Published: 2007

Journal Articles

Fc Engineered Anti-CD19 Monoclonal Antibodies with Enhanced In Vitro Efficacy Against Multiple Lymphoma Cell Lines.

Eugene A. Zhukovsky, PhD, Seung Chu, Ph.D., Matthew Bernett, Ph.D., Philip Hammond, Ph.D., Sher Karki, Ph.D., Wei Dang, Ph.D., Collin Edler, M.S., Nephi Polder, B.S., Cheryl Chan, B.S., Jonathan Jacinto, B.S., John Desjarlais, Ph.D.

Blood (2006) 108 (11): 4747.

https://doi.org/10.1182/blood.V108.11.4747.4747

Published: 2006

Journal Articles

The Shaving Reaction Is Facilitated through Trogocytosis: Concerted Transfer of Both Rituximab (RTX) and the Membrane Dye PKH26 from B Lymphocytes to Macrophages Is Demonstrable by Flow Cytometry, Fluorescence Microscopy, and High Resolution Digital Imaging in a Flow Cytometric Environment.

David A. Mack, MD, Paul V. Beum, PhD, Margaret A. Lindorfer, PhD, Andrew W. Pawluczkowycz, MS, Ronald P. Taylor, PhD

Blood (2006) 108 (11): 2096.

https://doi.org/10.1182/blood.V108.11.2096.2096

Published: 2006

Journal Articles

Flow Cytometry and Immunohistochemistry Analyses Reveal That Rituximab/CD20 Complexes Are Removed (Shaved) from Mantle Cell Lymphoma Cells (Z138) Previously Infused Intravenously or Subcutaneously in a SCID Mouse Model, and the Shaving Reaction Can Be Blocked by IVIG.

Ronald P. Taylor, PhD, Yongli Li, BS, Margaret A. Lindorfer, PhD, John B. Coursar, MD, Michael E. Williams, MD

Blood (2006) 108 (11): 2105.

https://doi.org/10.1182/blood.V108.11.2105.2105

Published: 2006

Journal Articles

Variant genotypes of FcγRIIIA influence the development of Kaposi's sarcoma in HIV-infected men

Thomas Lehr nbecher, Charles B. Foster, Shaoxian Zhu, David Venzon, Seth M. Steinberg, Kathleen Wyvill, Julia A. Metcalf, Sandra S. Cohen, Joseph Kovacs, Robert Yarchoan, Andrew Blauvelt, Stephen J. Chanock

Blood (2000) 95 (7): 2386–2390.

https://doi.org/10.1182/blood.V95.7.2386

Published: 2000

Journal Articles

Mechanisms of corticosteroid action in immune thrombocytopenic purpura (ITP): experimental studies using ITP-prone mice, (NZW x BXSB) F1

H Mizutani, T Furubayashi, Y Imai, H Kashiwagi, S Honda, H Take, Y Kurata, T Yonezawa, S Tarui, S Ikehara

Blood (1992) 79 (4): 942–947.

https://doi.org/10.1182/blood.V79.4.942.942

Published: 1992

NARROW

BI-1206, a Monoclonal Antibody Against Fcγriib, Showed Superior Anti-Tumor Activity in an Ibrutinib-Venetoclax Dual Resistant PDX Model in Mantle Cell Lymphoma

Prognostic Impact of Germ-Line FCGR2A (H131R), FCGR3A (F158V), and FCGR2B (I232T) Single Nucleotide Polymorphisms in Lymphoma Patients Treated with Obinutuzumab or Rituximab in Combination with Chemotherapy: Results from the Phase III GALLIUM and GOYA Clinical Trials

Use of Monoclonal Antibodies to RBC Antigens As a Therapeutic to Allow Incompatible Transfusion

Interim Results From a Phase Ib/IIa Clinical Trial with the Soluble Fc-Gamma IIb Receptor SM101 for the Treatment of Primary Immune Thrombocytopenia

Properties of mouse and human IgG receptors and their contribution to disease models

Human FcγRIIA induces anaphylactic and allergic reactions

Correlation of Fc Gamma RIIA Polymorphisms with EBV-Positivity and LMP1 Expression in Patients with Low Grade B-Cell Lymphomas

Comparison of Platelet-Activating Potential of Bevacizumab+VEGF and Aflibercept+VEGF Complexes

An Fc-Engineered Humanized Anti-CD40 Monoclonal Antibody, XmAb5485, Exhibits Potent Activity in Vitro and in Vivo against Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma

XmAb™ Fc Engineered Anti-CD19 Monoclonal Antibody with Enhanced In Vitro Efficacy Against Lymphoma and Leukemia.

Fc Engineered Anti-CD19 Monoclonal Antibodies with Enhanced In Vitro Efficacy Against Multiple Lymphoma Cell Lines.

The Shaving Reaction Is Facilitated through Trogocytosis: Concerted Transfer of Both Rituximab (RTX) and the Membrane Dye PKH26 from B Lymphocytes to Macrophages Is Demonstrable by Flow Cytometry, Fluorescence Microscopy, and High Resolution Digital Imaging in a Flow Cytometric Environment.

Flow Cytometry and Immunohistochemistry Analyses Reveal That Rituximab/CD20 Complexes Are Removed (Shaved) from Mantle Cell Lymphoma Cells (Z138) Previously Infused Intravenously or Subcutaneously in a SCID Mouse Model, and the Shaving Reaction Can Be Blocked by IVIG.

Variant genotypes of FcγRIIIA influence the development of Kaposi's sarcoma in HIV-infected men

Mechanisms of corticosteroid action in immune thrombocytopenic purpura (ITP): experimental studies using ITP-prone mice, (NZW x BXSB) F1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only